Key Highlights

  • Acadia Healthcare (NASDAQ:ACHC) reported third-quarter Revenue of USD 895.3 million, up 5.1% from USD 851.6 million, with same Facility revenue rising 5.2% on higher admissions and pricing.
  • Diluted earnings per share were USD 0.38 against USD 0.40 a year earlier, even though pretax income rose to USD 56.5 million from USD 40.0 million.
  • The effective tax rate jumped to 31.6% from 4.2%, mainly from nondeductible legal settlements and higher valuation allowances against certain state deferred tax assets.
  • Transaction, legal and other costs fell to USD 23.7 million from USD 42.9 million, as government investigation costs dropped to USD 18.3 million from USD 38.7 million.

Admissions Up 6.6% as Same Facility Revenue Climbs

Acadia Healthcare (NASDAQ:ACHC) filed its Quarterly Report on November 4, 2026, for the period ended September 30. The company runs behavioral healthcare facilities, and at quarter-end it operated 280 sites with about 12,800 beds across 40 states and Puerto Rico. Revenue grew 5.1% to USD 895.3 million. Same facility patient days rose 1.1% and admissions rose 6.6%, while revenue per patient day increased 4.0%, and average length of stay shortened by 5.1%. Over nine months, revenue was USD 2.59 billion, up 4.0%, and the company added 542 beds, including three joint venture hospitals opened with health system partners. The filing links patient day growth to bed additions at existing facilities and continued Demand for services.

Pretax Gain Erased by a 31.6% Tax Rate

Net income attributable to the company was USD 34.5 million versus USD 36.2 million, so diluted earnings fell to USD 0.38 from USD 0.40. The cause sits below the operating lines: income tax was USD 17.8 million compared with USD 1.7 million, because the prior-year quarter included a tax benefit from releasing uncertain tax positions. Salaries, wages and benefits took 54.8% of revenue against 54.3%, and professional fees rose to 6.6% of revenue from 6.0%. A legal settlements gain of USD 7.2 million, from insurance proceeds tied to derivative case settlements, helped. For nine months, diluted earnings were USD 0.54 against USD 0.82, and the company booked a USD 28.6 million unfavorable adjustment to its self-insured Liability estimates.

Cash Flow, Leverage and Medicaid Exposure

Cash from operations for nine months was USD 321.5 million compared with USD 218.2 million, helped by insurance proceeds from the 2019 securities litigation and state supplemental payments. Capital spending was USD 165.9 million, and the company repaid USD 215.0 million on its revolver while borrowing USD 85.0 million. Cash stood at USD 163.3 million, revolver availability was USD 710.1 million and net leverage under the Credit agreement was 3.9 times, within covenants. Risks include the One Big Beautiful Bill Act, which tightens Medicaid eligibility and caps certain state directed payments, and the filing says Days Sales Outstanding rose to 52 days at September 30 from 49 days at December 31, 2025, a sign that collections slowed slightly. Management also says legislation could change Medicaid and Medicare payments again.

Where Things Stand

Earnings slipped because of tax, not weaker operations. Acadia Healthcare (NASDAQ:ACHC) grew revenue 5.1%, lifted pretax income by about USD 16.5 million (calculated) and cut legal and investigation costs, yet a 31.6% tax rate pulled diluted earnings down to USD 0.38. The filing gives no guidance or consensus comparison. Watch the tax rate, labor and professional fee ratios, Medicaid policy changes and whether investigation costs keep shrinking.